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Abstract 
Therapeutic hypothermia was investigated repeatedly as a tool to improve the outcome of 
severe traumatic brain injury (TBI), but previous clinical trials and meta-analyses found 
contradictory results. We aimed to determine the effectiveness of therapeutic whole-body 
hypothermia on the mortality of adult patients with severe TBI by using a novel approach 
of meta-analysis. 
We searched the PubMed, EMBASE, and Cochrane Library databases from inception to 
February 2017. The identified human studies were evaluated regarding statistical, clinical, 
and methodological designs to ensure inter-study homogeneity. We extracted data on TBI 
severity, body temperature, mortality, and cooling parameters; then we calculated the 
cooling index, an integrated measure of therapeutic hypothermia. 
Forest plot of all identified studies showed no difference in the outcome of TBI between 
cooled and not cooled patients, but inter-study heterogeneity was high. On the contrary, 
by meta-analysis of RCTs which were homogenous with regards to statistical, clinical 
designs and precisely reported the cooling protocol, we showed decreased odds ratio for 
mortality in therapeutic hypothermia compared to no cooling. As independent factors, 
milder and longer cooling, and rewarming at < 0.25°C/h were associated with better 
outcome. Therapeutic hypothermia was beneficial only if the cooling index (measure of 
combination of cooling parameters) was sufficiently high. 
We conclude that high methodological and statistical inter-study heterogeneity could 
underlie the contradictory results obtained in previous studies. By analyzing 
methodologically homogenous studies, we show that cooling improves the outcome of 
severe TBI and this beneficial effect depends on certain cooling parameters and on their 
integrated measure, the cooling index. 
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Introduction 
Traumatic brain injury (TBI) is recognized as a significant cause of mortality and 
morbidity predominantly in the young population.1 TBI is estimated to affect 10 million 
people annually worldwide and by 2020 it can be one of the major causes of death and 
disability, posing a global health and financial burden for the society.2 Among the leading 
causes of TBI are motor vehicle accidents in both more and less developed countries, most 
frequently involving young males.2, 3 Mild head injuries may recover fully without any 
specific treatment, whereas severe injuries are often rapidly fatal or leave survivors with 
disabilities.4 Severe TBI constitutes a major health and socio-economic problem 
worldwide.5  
The pathomechanisms underlying severe TBI are complex and often involve focal as 
well as diffuse changes.6 Focal lesions include contusional damages of the brain 
parenchyma, most commonly in the frontal and temporal lobes, as well as disruptions in 
vasculature, resulting in intracerebral and extracerebral heamatomas.5, 6 In a typical case 
like the one presented in Table S1, focal lesions are diagnosed with routine imaging 
techniques, such as computed tomography (see Fig. S1). The primary head injury can 
initiate a number of pathophysiological processes which will determine the extent and the 
duration of the damage. These mechanisms involve ischemia, swelling (edema), 
neurotransmitter release (excitotoxicity), formation of free radicals, ionic flux-mediated 
damage, metabolic and mitochondrial dysfunction, and neuroinflammatory responses.4-6  
Many of the pathological mechanisms associated with TBI are temperature-
sensitive,7 suggesting that at a lower deep body temperature the adverse processes can be 
decelerated and neuroprotective effects can be achieved. Therapeutic hypothermia has 
been investigated as a possible neuroprotective strategy to attenuate the harmful effects 
of severe TBI. In animal models of TBI, beneficial effects of therapeutic hypothermia have 
been shown repeatedly,8-11 but clinical studies provided contradictory results. The first 
report of the use of hypothermia in TBI was in 1943,12 while randomized controlled studies 
appeared only at the end of the 1990s.13 Over the last 25 years, numerous clinical trials 
have been conducted to assess the effects of induced hypothermia in severe TBI.13-31 
Cooling of patients with severe TBI improved the outcome in several of these studies,14, 17, 
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21, 23, 25, 26, 29-32 while other trials suggested weak or no evidence for the use of therapeutic 
hypothermia following TBI.16, 20, 27, 33-35 It has to be noted that the study design (e.g., 
randomization), inclusion criteria of patients, and the applied cooling protocol varied 
substantially among the trials, which differences could have contributed to the 
contradictory findings in the human studies. 
As attempts to ultimately answer the question of whether therapeutic hypothermia 
improves the outcome of TBI, several meta-analyses have also been performed.36-42 
However, the different analyses provided contradictory results. While, about half of them 
showed that therapeutic hypothermia might be effective in the treatment of TBI and could 
reduce mortality,36, 38, 39, 41 the other half indicated that it did not decrease the mortality 
rate.37, 40, 42 It can be assumed that the high inter-study variability in the statistical and 
clinical designs of the trials, which were included in some of the meta-analyses and the 
different study selection protocols were responsible for the contradictory results. Indeed, 
high inter-study heterogeneity was reported in all of the performed meta-analyses so 
far.36-42 
In the present study, we used a novel approach to determine the efficacy of 
therapeutic hypothermia in TBI. In our meta-analysis, we carefully evaluated all studies 
identified by literature search based on statistical design, patient inclusion criteria, and the 
applied cooling protocol, thereby we identified studies which were homogenously 
designed from three aspects: statistically (randomization), clinically (whole-body cooling 
versus no temperature management of patients with severe TBI), and methodologically 
(cooling protocols precisely reported). Then, we conducted meta-analyses of these studies 
to evaluate the effects of therapeutic hypothermia as well as that of the individual 
parameters of the cooling protocol on the mortality rate of patients with severe TBI. We 
introduced the cooling index, an integrated measure of therapeutic hypothermia 
calculated from three different cooling parameters, and studied its relation to mortality in 
severe TBI. 
Methods 
Our meta-analysis was conducted in accordance with the guidelines of the 
Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (Table 
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ite
it 
U
tre
ch
t f
ro
m
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
4/
21
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Page 6 of 52 
 
 
 
6 
Jo
ur
na
l o
f N
eu
ro
tr
au
m
a 
Th
er
ap
eu
tic
 w
ho
le
-b
od
y 
hy
po
th
er
m
ia
 re
du
ce
s m
or
ta
lit
y 
in
 se
ve
re
 tr
au
m
at
ic 
br
ai
n 
in
ju
ry
 if
 th
e 
co
ol
in
g 
in
de
x i
s s
uf
fic
ie
nt
ly
 h
ig
h:
 m
et
a-
an
al
ys
es
 o
f t
he
 e
ffe
ct
 o
f s
in
gl
e 
co
ol
in
g 
pa
ra
m
et
er
s a
nd
 th
ei
r i
nt
eg
ra
te
d 
m
ea
su
re
 (D
OI
: 1
0.
10
89
/n
eu
.2
01
8.
56
49
) 
Th
is 
pa
pe
r h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 co
py
ed
iti
ng
 a
nd
 p
ro
of
 co
rr
ec
tio
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f. 
S2).43 The analysis was based on the Participants, Intervention, Comparison, Outcome 
(PICO) model: in severe TBI population, we aimed to assess the effect of therapeutic 
whole-body hypothermia compared to no cooling on the mortality ratio. This meta-
analysis has been registered with PROSPERO International Prospective Register of 
Systematic Reviews (CRD42017056535). 
Literature Search 
A systematic search of the PubMed, EMBASE, and Cochrane Library databases was 
performed from inception to February 2017 with using the following Medical Subject 
Headings and search terms: (“hypothermia” OR “cooling”) AND (“traumatic brain injury” 
OR “TBI”) AND (“mortality” OR “death” OR “survival”). Then, the “human” filter was 
selected. We restricted our search to original studies published in English without time 
period limitations. We included journal articles of the following study types: clinical study, 
clinical trial, comparative study, controlled clinical trial, controlled study, multicenter 
study, observational study, and randomized controlled trial. 
The search for the articles was conducted separately by two authors (EO and AG), 
who also assessed study eligibility, and extracted data from the selected studies 
independently. Disagreements were resolved by consensus with the help of a third author 
(ZR).  
Data Extraction 
Only those studies were included in the meta-analyses, in which the effect of 
therapeutic hypothermia was compared with no cooling interventions on the mortality 
ratio of adult patients with severe TBI. Nineteen RCTs13, 14, 16, 18, 20-31, 44-46 and eight 
articles15, 17, 19, 34, 47-50 of other study types were eligible for meta-analysis. The relevant 
data were extracted from these studies by two investigators (EO and AG) independently 
into Microsoft Excel software (Microsoft Corporation, Redmond, WA, USA). The following 
information was collected from each of the selected articles: authors’ names and date of 
publication, study type and randomization, characteristics of patient population [e.g., 
mean age, sample size, intracranial pressure (ICP), and Glasgow coma score (GCS) at 
admission], methods of whole-body cooling (target temperature, duration of hypothermia, 
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and rate of rewarming), interventions in the no cooling group, and mortality rates in the 
study groups. 
Data evaluation protocols 
The collected data were evaluated based on a statistical and a biomedical 
approach. Statistically, we assessed the randomization of the collected studies based on 
the authors’ statements, Jadad analysis, and detailed evaluation of the randomization 
protocol described in the study (see Quality assessment). In the biomedical evaluation, we 
narrowed the list of eligible studies to those that dealt with the effects of therapeutic 
whole-body hypothermia compared with no temperature management, therefore, we 
excluded those articles, in which selective brain cooling,44, 46, 51 or fever control with 
antipyretics34, 47, 48 was used, or when patients with spontaneous hypothermia were 
involved in the study.49, 52 Eligible studies resulting from the statistical or the biomedical 
refinement or both were compared with the random effect model of meta-analysis for 
odds ratio (OR) as effect size. To assess which parameters of the cooling methods have the 
biggest impact on the outcome of severe TBI, the studies were divided into subgroups 
based on target cooling temperature, cooling duration, and speed of rewarming. Target 
cooling temperatures were classified a priori as “moderate” (32-33°C)53 and “mild” (33-
35°C).29, 53 Cooling duration was divided into short (24-48h) and long (>48h) subgroups.54 
According to recent recommendations about the use of very slow (0.1-0.2°C/h) rewarming 
rates in patients with severe TBI,55, 56 the speed of rewarming was divided into either of 2 
subgroups: 0.25-1°C/h and less than 0.25°C/h, also including passive. Rewarming was 
determined passive if the cooling process ensued without induction of any cooling or 
rewarming device within the next 18-24 hours.57, 58 For quantification purposes, the speed 
of passive rewarming was considered to equal 0.06°C/h.57, 58 
In addition to analyzing the effect of each cooling parameter individually, the 
influence of the used combinations of the three parameters together was also assessed on 
the outcome of severe TBI. When all three parameters, i.e., target cooling temperature, 
cooling duration, and speed of rewarming, were reported in the same study, we calculated 
the integrated measure of cooling and named it as the cooling index. The cooling index 
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represents the area between the body temperature curve of cooled patients and a 
hypothetical horizontal line corresponding to a normal body temperature of 36.5°C (Fig. 
S2). The following formula was used: “cooling index” = ΔT × t + (ΔT × ΔT/R)/2, where “ΔT” 
is the magnitude of hypothermia, i.e., the difference between normal (36.5°C) and target 
cooling temperatures expressed in °C; “t” is duration of the maintenance of hypothermia 
in hours; and “R” is the rate of rewarming (°C/h); see also Fig. S2A. The impact of the 
rewarming rate was incorporated in the cooling index as the area of the triangle, which 
represents the change in body temperature during the rewarming phase. It has to be 
noted that due to the relatively narrow range (0.06-1°C/h) of the rewarming rates used in 
the analyzed studies, this area had the smallest contribution to the final value of the 
cooling index, while depth and duration of the cooling were more dominant contributors. 
The cooling index corresponds with the integrated measure of the magnitude and duration 
of therapeutic hypothermia. For example, a similarly high cooling index can result from 
short and deep cooling with rewarming at 0.25°C/h (Fig. S2B), as well as from longer, but 
milder cooling with slower, passive rewarming (Fig. S2A). A moderate cooling index can 
result from mild and short cooling followed by slow rewarming at ~ 0.08°C/h (Fig. S2C), 
while cooling index is low if cooling duration is brief and rewarming is faster (1°C/h) even if 
target cooling temperature is very low (Fig. S2D). For meta-analysis, the included studies 
were evenly distributed (N = 4) into subgroups with low (< 160°C × h), moderate (160-
200°C × h), and high (> 200°C × h) cooling index. Examples for the assessment of the 
cooling index in each of the three subgroups are presented in Figure S2. 
In five of the analyzed studies,14, 25, 26, 29, 31 the cooling protocol was changed 
depending from the ICP. Thus, we also compared whether the outcome of TBI differed 
between the group of studies which reported adjustments in the cooling protocol based 
on ICP and the group of studies which did not. 
Quality assessment  
To evaluate the quality of the included trials, two independent reviewers (EO and 
ZR) assessed the bias of the included studies according to the Cochrane Handbook.59 The 
methodology described for random sequence generation, allocation concealment, blinding 
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of participants and personnel, blinding of outcome assessment, completeness of outcome 
data, and selective outcome reporting was assessed during the analysis. Due to the nature 
of the studies eligible for our meta-analyses, the blinding method could not be assessed. 
The Jadad score, a five-point quality scale was used also to analyze the quality of the 
articles.60 Furthermore, an additional three-step evaluation of the randomization used in 
each study was performed, which was more relevant for such studies included in our 
meta-analysis. The first two questions of this evaluation were similar to those of the Jadad 
score, viz., whether the use of randomization was stated and whether the randomization 
procedure was appropriate and reported in the study. In the third step, the level of 
randomization was determined as good, if the use of randomization, and its exact protocol 
was reported in the study. If the use of randomization was stated, but the exact method 
was not described, the randomization level was assessed as medium, while in cases when 
the authors did not mention randomization, the level of randomization was considered 
low. This evaluation was necessary, because there were several studies in which the use of 
randomization was stated, but the exact method was not described,21, 23, 25, 27-31 which 
leaves the statement open for questions. 
Statistical Analysis 
The statistical analysis was performed according to the standard methods of meta-
analysis. The primary effectiveness outcome was all-cause mortality. OR with 95% 
confidence intervals (CI) for mortality in the adult patients with severe TBI were calculated 
in a random-effects model of meta-analysis. Summary effect estimates were stratified by 
study design and the between-groups effects were assessed. 
Publication bias was assessed with funnel plots by using the Duval and Tweedie 
trim and fill method61 and the Egger’s test (Egger’s test values of less than 0.1 were 
considered as indicators of significant small-study effect) (see Supplementary material). 
Between-study heterogeneity was tested with Q homogeneity test (p values of less than 
0.05 were considered as indicators of significant heterogeneity) and with I2 statistical test, 
where I2 is the proportion of total variation attributable to between-study variability (an I2 
value of more than 50 was considered as indicating considerable heterogeneity). Results of 
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the meta-analyses are depicted as forest plots. All analyses were performed using the 
Comprehensive Meta-Analysis software (version 3.3; Biostat, Inc., Engelwood, MJ, USA).  
Results 
Study selection  
The flow chart of the study selection is presented in Figure 1. Until February 23, 
2017 the literature search identified altogether 709 studies from the PubMed, EMBASE, 
and Cochrane databases. After enabling filters for human studies and English language and 
using additional filters (study types) 321 studies remained, which were screened for title 
and abstract for inclusion criteria. 273 articles were excluded because of insufficient data 
reporting or because children were studied. 48 studies were included in qualitative 
synthesis. A further 21 articles were excluded due to the lack of mortality data. 27 studies 
were included and pooled for quantitative synthesis. 
When we compared the effects of therapeutic hypothermia with no cooling by 
including all 27 identified studies in the meta-analysis (Fig. S3), we did not find a significant 
difference in the OR for mortality between the groups. Importantly, the included studies 
were methodologically quite heterogeneous with regards to both statistical and clinical 
designs (Q = 167, p < 0.001; I2 = 84). 
As a statistical approach to reduce heterogeneity, we analyzed separately those 
nineteen studies which could be considered as RCTs (Fig. S4). Therapeutic hypothermia 
tended to improve the outcome in patients with severe TBI, but the difference did not 
reach the level of significance (OR = 0.782; p = 0.075). However, between-study 
heterogeneity was still reasonably high as indicated by the nearly significant result of the Q 
homogeneity test (p = 0.053). Based on detailed quality assessment of the randomization 
protocols in the studies, the level of randomization was assessed as good in 3 studies, 
medium in 9 studies, and low in 2 studies (Table S3). The remaining 5 RCTs were not 
included in this assessment, as they did not pass the criteria set for homogenous clinical 
and methodological designs (see below). The use of therapeutic hypothermia significantly 
decreased the risk of mortality in the subgroup of medium randomization level (OR = 
0.676; p = 0.041), while no significant difference was found between cooling versus no 
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ite
it 
U
tre
ch
t f
ro
m
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
4/
21
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Page 11 of 52 
 
 
 
11 
Jo
ur
na
l o
f N
eu
ro
tr
au
m
a 
Th
er
ap
eu
tic
 w
ho
le
-b
od
y 
hy
po
th
er
m
ia
 re
du
ce
s m
or
ta
lit
y 
in
 se
ve
re
 tr
au
m
at
ic 
br
ai
n 
in
ju
ry
 if
 th
e 
co
ol
in
g 
in
de
x i
s s
uf
fic
ie
nt
ly
 h
ig
h:
 m
et
a-
an
al
ys
es
 o
f t
he
 e
ffe
ct
 o
f s
in
gl
e 
co
ol
in
g 
pa
ra
m
et
er
s a
nd
 th
ei
r i
nt
eg
ra
te
d 
m
ea
su
re
 (D
OI
: 1
0.
10
89
/n
eu
.2
01
8.
56
49
) 
Th
is 
pa
pe
r h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 co
py
ed
iti
ng
 a
nd
 p
ro
of
 co
rr
ec
tio
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f. 
cooling in the other two subgroups (Fig. S5). When the good and medium subgroups were 
merged, their pooled OR remained significantly lower than 1 (OR = 0.66, p = 0.003), which 
indicated better outcome in therapeutic hypothermia, but clinically, the inter-study 
heterogeneity was still considerably high. 
We evaluated the studies based on clinical and methodological designs. Our goal 
was to study the effect of therapeutic hypothermia applied to the whole body of patients 
with severe TBI, but without spontaneous hypothermia and without temperature control. 
Therefore, 3 trials using selective brain cooling,44, 46, 51 2 articles including cases of 
spontaneous hypothermia,49, 52 and 3 studies applying fever control34, 47, 48 had to be 
excluded from the analysis. Further 4 studies could not be included in the final analyses, 
because the applied cooling methods were not reported in sufficient details.15, 18, 19, 22 In 
one of the trials GCS of the included patients ranged between 3-15,16 which sample also 
includes mild (GCS = 13-15) and moderate cases of TBI (GCS = 9-12), therefore it also had 
to be excluded from further analysis (Fig. 1). 
As result of the combined (statistical and physiological) evaluation of the studies 
identified by our literature search, 14 full-text publications (involving 1,786 adult patients 
with severe TBI; 896 in the therapeutic hypothermia group and 890 in the no cooling 
group), were included in the next steps of our analysis. The descriptive statistics of the age, 
GCS, ICP, and injury severity score in the patient populations from these 14 studies are 
presented in Table 1. These data reported from a big patient population (N > 1,700) 
correspond with the clinical parameters observed in the patient presented in Table S1. The 
publication years of the studies ranged from 1993 to 2017. All of them can be considered 
as randomized trials, in which the exact cooling methods of the whole body (target 
temperature, cooling duration, and speed of rewarming) are reported, and the effect of 
therapeutic hypothermia on mortality was compared with patients without temperature 
management in severe TBI. The homogeneity of the studies was verified by Egger’s test, Q, 
and I2 statistics, which showed no significant difference in inter-study variability (Egger’s p 
= 0.509; Q = 17, p = 0.224; I2 = 21). Meta-analysis of these studies revealed that 
therapeutic hypothermia significantly improved the outcome of severe TBI (OR = 0.675; p = 
0.004) (Fig. 2). 
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Next, we studied the different parameters of the cooling protocol viz., target 
temperature, cooling duration, and speed of rewarming. Based on target cooling 
temperatures 4 studies used “moderate” (equal or less than 33°C) and 7 studies “mild” 
(33-35°C) hypothermia, while in 3 studies the reported target temperature range 
overlapped between the moderate and mild groups (Fig. 3). We found that the use of mild 
therapeutic hypothermia considerably improved the outcome (decreased the risk of 
death) as compared with no cooling (OR = 0.627; p = 0.050). No significant differences 
were found in the moderate hypothermia and the overlapping target temperature groups 
(Fig. 3). With regards to cooling duration, in 9 studies short (24-48h) hypothermia was 
used, while in 5 studies cooling was longer than 48 hours (Fig. 4). The effect of long-term 
hypothermia was beneficial on the mortality rate of patients with severe TBI compared to 
patients with no temperature management (OR = 0.534; p < 0.001), while in case of short-
term hypothermia the effect was not significant (Fig. 4). Based on the speed of rewarming, 
the studies were divided into subgroups using rewarming rates of either 0.25-1°C/h or less 
than 0.25°C/h. We found that therapeutic hypothermia improved the outcome of severe 
TBI when the rewarming rate was below 0.25°C/h (OR = 0.58; p = 0.014), while there was 
only a tendency for the better outcome when rewarming rate was ≥ 0.25°C/h (OR = 0.74; p 
= 0.085) (Fig. 5). These results suggest that certain parameters of the cooling protocol can 
be associated with more beneficial effects of therapeutic hypothermia on the mortality of 
patients with severe TBI, but how the combination of the different parameters together, 
i.e., the total extent of cooling, contributes to the outcome could not be firmly established. 
In our next approach, we studied the integrated effect of the cooling parameters 
on the outcome of the disease. From the cooling parameters reported in the studies with 
medium and good level of randomization (Table S3), the cooling index was assessed by 
considering all three variables, viz., target temperature, cooling duration, and speed of 
rewarming, in the formula (for details, see Methods and Fig. S2A). The reported 
parameters and the cooling index derived from these data are shown in Table 1. By 
calculating the cooling index, we were able to compare the effect of the overall extent of 
hypothermia among studies which used different cooling parameters in their protocols. 
The OR (estimated expected average) in the subgroups with low (< 160°C × h), moderate 
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(160-200°C × h), and high (> 200°C × h) cooling index was 0.831 (p = 0.535), 0.754 (p = 
0.340), and 0.470 (p = 0.035), respectively (Fig. 6). Importantly, the only significant effect 
for an OR of less than 1, i.e., when cooling was beneficial compared to no cooling, was 
observed in the subgroup of studies with high cooling index. These results suggest that in 
addition to the different independent contribution of each cooling parameter, the 
integrated measure of the magnitude and duration of therapeutic hypothermia (as 
indicated by the cooling index) can play a decisive role in determining whether the applied 
cooling protocol will decrease the risk of death in patients with severe TBI. 
We also evaluated whether adjustments of the cooling parameters depending from 
the ICP of the patients impacts the outcome in severe TBI. When we compared the 
outcome of TBI between the group of studies which adjusted the cooling protocols based 
on ICP with the group of studies which did not, we found that when ICP was taken into 
account, the effect of therapeutic hypothermia was beneficial on the mortality rate of 
patients with severe TBI compared to patients with no temperature management (OR = 
0.53; p < 0.001), while the beneficial effect was not significant when the cooling protocol 
was not changed depending from ICP (OR = 0.85; p = 0.265) (Fig. 7). These results support 
the necessity of monitoring ICP and adjusting the cooling parameters depending from ICP 
during therapeutic hypothermia. 
Discussion 
In the present study, we show that whole-body cooling decreases the risk of death 
in patients with severe TBI by conducting meta-analysis of clinical studies, which were 
homogenous with regards to statistical, clinical, and methodological designs. By analyzing 
the individual cooling parameters, we reveal that milder and longer cooling and slower 
rewarming speed than 0.25°C/h are the most important to improve the outcome of severe 
TBI. We introduce the cooling index to assess the overall extent of cooling, and show that 
therapeutic hypothermia is beneficial in severe TBI only if the cooling index is sufficiently 
high. 
Our findings are in line with several clinical trials showing a beneficial effect of 
therapeutic hypothermia on the outcome of severe TBI,13, 14, 17, 21, 23, 25, 26, 29-31 whereas they 
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contradict other trials which found no or even adverse effect of whole-body cooling in 
TBI.20, 24, 27, 28 Differences in statistical, clinical, and methodological designs among the 
studies can be assumed to account for the contradictory results. The highest quality 
human studies are RCTs, while observational studies and retrospective analyses provide 
lower level of evidence. Among RCTs the randomization protocol can vary (see Table S3), 
which results in different levels of statistical bias involved in the trials. Three multi-center 
clinical trials20, 27, 28 found either no change or worse mortality rates in the cooled groups 
of patients with TBI, whereas all of the single-center studies13, 14, 17, 21, 23, 25, 26, 29-31 showed 
that therapeutic hypothermia was associated with a lower mortality rate. Differences 
between results from single-center versus multi-center trials have been observed earlier 
with regards to therapeutic hypothermia.62 Large multi-center trials are usually considered 
as higher quality studies than single-center trials mostly when pharmacological treatments 
are investigated, however, when precise execution of the studied intervention is crucial as 
in the case of therapeutic hypothermia, then the different protocols used in different 
centers can lead to heterogeneous results, which can mask the differences between the 
treated and control groups. The study type and randomization level should be taken into 
account when the findings of a study are evaluated and, especially, when several studies 
are compared with meta-analysis. 
At least in some cases the clinical design of the studies could clearly contribute to 
mask the effects of therapeutic hypothermia on the outcome. In the study by Andrews et 
al.16 an adverse effect of therapeutic hypothermia on the outcome of TBI was found, 
however, patients with GCS of 3-15 were included in the trial and subgroup analysis for the 
different severities of TBI was not performed. Furthermore, it can be assumed that the 
deleterious effects of cooling on the outcome could be attributable to the different 
conventional treatments, which were not controlled for between groups.63 Clifton et al.30 
could not confirm the efficacy of therapeutic hypothermia in TBI, which contradicted the 
results of an earlier phase 2 trial.27 However, patients with spontaneous hypothermia were 
also included in the study,30 which could have influenced the results. As opposed to 
therapeutic hypothermia when deep body temperature decreases due to forced cooling, 
spontaneous hypothermia is regarded as a regulated, adaptive mechanism in response to 
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severe forms of a disease (e.g., systemic inflammation),64 and it is often associated with 
worse outcome.65 In some studies the authors used fever control,34, 47, 48 which could also 
influence the results. Most of the antipyretics (e.g., NSAIDs) do not only reduce fever, but 
also exert anti-inflammatory and other effects. It has been shown that unlike the use of 
antipyretics, fever was not associated with mortality in systemic inflammation,66 
suggesting different biological and clinical implications of fever and antipyretics.66 Since 
inflammatory processes are also involved in the pathomechanism of severe TBI,4-6 the use 
of antipyretics in the control (no cooling) group could change the outcome of the disease. 
Methodologically, studies using selective brain cooling44, 46, 51 should be 
distinguished from those applying whole-body hypothermia, because selective brain 
cooling is occasionally invasive, and if maintained for several hours, it may induce systemic 
hypothermia.67 A critical appraisal of published clinical studies showed that the methods of 
therapeutic hypothermia were heterogeneous in terms of timing, depth, duration, and 
rewarming rate.68 The impact of the different cooling methods on the outcome can be 
reduced if exclusively those studies are compared, in which the cooling parameters are 
precisely reported, and the role of the parameters is also analyzed. 
Previous meta-analyses of the available data from the clinical trials lead to 
contradictory results regarding the efficacy of therapeutic hypothermia in TBI.36-42 It can be 
assumed that the substantial heterogeneity among the trials included in these meta-
analyses could be a crucial factor, which influenced the outcome of the analysis. By using 
meta-analysis, weighting of the included results can be based only on the deviation 
reported in a trial. The more uncertain data (greater variability, smaller sample) are taken 
into account with a lesser weight, but the selection of the studies cannot be accounted for. 
The novel approach in our meta-analysis is that we extended the conventionally used 
protocols for study selection by detailed evaluation of the statistical, clinical, and 
methodological design of the studies. As a result, we identified a group of studies which 
were homogenous with regard to all three evaluated aspects of the design. By analyzing 
the results reported in these studies, we found that therapeutic hypothermia improves the 
outcome of severe TBI and its beneficial effect can be associated with certain cooling 
parameters (milder and longer cooling, and slower rewarming than 0.25°C/h). Our results 
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about the importance of slow rewarming are well in agreement with data obtained from 
experimental animals showing that hypothermia followed by slow rewarming provides 
maximal neuroprotective effect,69, 70 and further support the current recommendations 
about the use of very slow (0.1-0.2°C/h) rewarming rates in patients with severe TBI.55, 56 
On the contrary, the use of uncontrolled rewarming may potentially offset the benefits of 
hypothermia, particularly because it may cause rebound intracranial hypertension.13, 30 
Nevertheless, it also has to be noted that since the reported rewarming rates covered only 
a narrow range, an extended analysis, which would take in account fast, moderate, and 
slow rewarming of the patients, could not be performed in our study and that the 
contribution of rewarming to the cooling index was smaller than that of the other two 
cooling parameters. Importantly, different combinations of the studied parameters can be 
also advantageous if the total extent of hypothermia (cooling index) is sufficiently high. A 
high cooling index (~ 230°C × h), thereby beneficial effect of therapeutic hypothermia 
could be achieved by different combinations of the cooling parameters, e.g., by short (48h) 
and deep (32.5°C) cooling followed by rewarming at a rate of 0.25°C/h,30 as well as by 
longer (72h) and milder (34°C) cooling followed by slower (0.06°C/h) rewarming23 (also 
compare with Fig. S2A and B). By looking at the single cooling parameters used in the two 
studies,23, 30 the effect of therapeutic hypothermia on the outcome could seem 
controversial, as moderate and short cooling30 with slower rewarming23 were not 
beneficial, while milder and longer hypothermia23 with not so slow rewarming30 improved 
the outcome in severe TBI. However, if the integrated measure of the magnitude and the 
duration of cooling is considered, viz., the cooling index, then a high extent of hypothermia 
can be demonstrated in both studies,23, 30 resulting in a beneficial effect of whole-body 
cooling on the outcome of severe TBI as seen in the subgroup with high cooling index (OR 
= 0.47; Fig. 6). Since the clinical data of the patient presented in Table S1 are similar to the 
analyzed patient population, it is tempting to speculate that cooling of this patient with 
the methods specified above could have improved the outcome in his case. Our meta-
analysis included data from a total of 1,786 adult patients with severe TBI, but due to the 
nature of this method, we have studied the reported mean in populations of patients, 
rather than the association in individual subjects. Therefore, precisely designed clinical 
trials are needed to confirm our results in clinical settings. The design of such trials should 
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include appropriate randomization protocols, targeted population of patients (severe TBI, 
no pre-existing thermoregulatory disorders, no differences between the study and control 
groups in medical-surgical treatment), and precise cooling protocols (a combination of 
parameters with sufficiently high cooling index). By validation of our findings in clinical 
trials, it would be possible to identify a subpopulation of patients with TBI, in which well-
controlled therapeutic cooling could improve the outcome.  
The addition of further patient characteristics (e.g. ICP, age, comorbidities) and 
methodological parameters (e.g., initiation time of cooling) to the inclusion criteria of such 
trial, could help to accurately specify the patient population which can benefit the most 
from precisely conducted therapeutic hypothermia. Increased ICP can be regarded as both 
an indicator of the actual brain damage and as a cause of additional pathological changes 
in severe TBI.55 A strong body of evidence supports that therapeutic hypothermia is a 
useful tool to decrease ICP in TBI, however this does not necessarily improve the outcome 
of the disease.68 The contradiction between the management of intracranial hypertension 
and the lack of improvement in the outcome can be due to inadequate maintenance of the 
hypothermia-induced lower ICP, because of the applied cooling protocol. Rebound 
increases of ICP are more common in patients with TBI if the cooling duration is too short 
and the rate of rewarming is too fast.53 To avoid the adverse changes in ICP, five of the 
analyzed studies reported that the designed cooling protocol was adjusted based on the 
ICP.14, 25, 26, 29, 31 Here, we showed that in these studies therapeutic hypothermia 
significantly improved the outcome in severe TBI compared to those trials which followed 
the protocol regardless of ICP.8, 13, 17, 20, 23, 24, 27, 28, 30 These results highlight the importance 
of continuous ICP monitoring during therapeutic hypothermia and warrant for the need of 
adjustments in the cooling protocol based on ICP. Unfortunately, the data about the 
deviations from the set protocols were not reported in sufficient details in any of the 
studies, in order to account for the changes in our calculation of the cooling index. It would 
also be interesting to study how pharmacological tools can be implemented in the 
induction of hypothermia in addition to external cooling of the body. Ideal candidates for 
such drugs could be among the new generation of the antagonists of the transient 
receptor potential vanilloid-1 channel, which were developed as painkillers, but can cause 
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marked hypothermia.71 These additional parameters could not be included in the present 
meta-analysis because of insufficient data availability. Due to the same reason, the upper 
limit of the cooling index, i.e., above which the harmful effect of hypothermia would 
dominate over the beneficial effects, could not be determined in our analysis. In the 
included trials, even from which the highest cooling indices were calculated, cooling of the 
patients improved the outcome.21, 23, 29, 30 It can be expected that the upper safety limit of 
the cooling index would need to be established separately for the different study 
populations. Identification of the exact cooling protocol for a specified patient population 
would be in line with recent paradigms in the treatment of TBI, suggesting the need for 
targeted management of individuals or subsets of patients to improve the outcome.72, 73 
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Table 1 Characteristics of the patient groups with severe TBI in the studies included in the meta-analyses. 
Study 
Mea
n 
age 
(yea
r) 
GCS 
Treatmen
t 
Number 
of 
patients 
(N) 
ICP (mmHg) ISS 
Cooling 
duration 
(h) 
Target 
temperature 
(°C) 
Rewarm
ing rate 
(°C/h) 
Cooling 
index 
(°C × h) 
Cooling 
index 
subgroup 
Clifton 
(1993) 
29.1 4-7 
Cooling 24 14.5 NR 48 32-33 0.25 224 high
No cooling 22 16.4 NR      
Clifton 
(2001) 
31.5 3-8 
Cooling 190 18.1 28 ± 9 48 32.5-34 0.25 177 moderate
No cooling 178 17.9 28 ± 8      
Clifton 
(2011) 
28.5 3-8 
Cooling 52 NR 30 ± 6 48 33-34 0.25 162 moderate
No cooling 45 NR 30 ± 9      
Hashiguchi 
(2003) 
34.1 3-8 
Cooling 9 11.1 ± 4.8 30.7 ± 5.6 48 33.5-34.5 ~ 0.08 159 low
No cooling 8 11.9 ± 4.2 33.0 ± 6.4      
Jiang (2000) 41.4 3-8 
Cooling 43 29.6 ± 2.2 NR 72-336 33-35 1 243 high
No cooling 44 30.3 ± 3.0 NR      
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Liu (2015) NR 3-8 Cooling 110 27.5 ± 16.9 NR 72-288 35-36 < 0.25 − −
No cooling 110 26.8 ± 17.5 NR  
Marion 
(1997) 
33.5 3-7 
Cooling 40 15.4 NR 24 32-33 1 104 low
No cooling 42 19.7 NR      
Polderman 
(2002) 
36.7 3-8 Cooling 64 37.0 ± 20.0 NR 24 32 0.08 − −No cooling 72 ˂ 20.0 NR  
Shiozaki 
(1993) 
35.4 <8 Cooling 16 35.4 ± 12.0 NR 48 33.5-34.5 passive 172 moderateNo cooling 17 36.9 ± 12.1 NR  
Shiozaki 
(2001) 
38.5 3-8 Cooling 45 NR NR 48 33.5-34.5 ~ 0.08 159 lowNo cooling 46 NR NR      
Smrcka 
(2005) 
41.0 3-8 
Cooling 35 NR 11.8 ± 5 72 34 passive 232 high
No cooling 37 NR 17.6 ± 7      
Tang (2017) 41.1 3-8 Cooling 30 NR NR 48 32-35 0.25 162 moderate
No cooling 30 NR NR  
Zhao (2011) 37.2 3-8 Cooling 40 15.9 ± 4.3 NR 72 32.5-33 passive 387 high
No cooling 41 17.1 ± 5.0 NR  
Zhi (2003) 42.5 3-8 Cooling 198 26.9 ± 4.6 NR 24-168 32-35 0.25 138 lowNo cooling 198 26.6 ± 4.9 NR      
−, not applicable; GCS, Glasgow coma score; ICP, intracranial pressure; ISS, injury severity score; NR, not reported. 
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FIGURE LEGENDS 
 
Figure 1 Flow chart of study selection and inclusion. 
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Figure 2 Forest plot of the odds ratios for mortality rate between cooled and not cooled 
groups of patients with severe TBI using random-effects model in statistically, clinically, 
and methodologically homogenous RCTs. 
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Figure 3 Forest plot of the odds ratios for mortality rate between cooled and not cooled 
groups of patients with severe TBI using random-effects model in RCTs divided into 
moderate (32-33°C; group label 1), mild (33-35°C; group label 2), and overlapping (32-35°C; 
group label 3) hypothermia subgroups based on target cooling temperature. Here and in 
Figures 4-6, the lines marked with * denote the mean values of the respective subgroups. 
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Figure 4 Forest plot of the odds ratios for mortality rate between cooled and not cooled 
groups of patients with severe TBI using random-effects model in RCTs divided into long (> 
48h; group label 1) and short (24-48h; group label 2) subgroups based on cooling duration. 
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Figure 5 Forest plot of the odds ratios for mortality rate between cooled and not cooled 
groups of patients with severe TBI using random-effects model in RCTs divided into 2 
subgroups based on rewarming rate: less than 0.25°C/h (group label 1) and 0.25-1°C/h 
(group label 2). 
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Figure 6 Forest plot of the odds ratios for mortality rate between cooled and not cooled 
groups of patients with severe TBI using random-effects model in RCTs divided into low (< 
160°C × h; group label 1), moderate (160-200°C × h; group label 2), and high (> 200°C × h; 
group label 3) subgroups based on the cooling index. 
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Figure 7 Forest plot of the odds ratios for mortality rate between cooled and not cooled 
groups of patients with severe TBI using random-effects model in RCTs divided into 2 
subgroups: cooling protocol adjustments based on ICP (group label 1) and no ICP-based 
changes in the protocol (group label 2). 
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Table S1. Characteristics of a patient with severe TBI admitted to one of our centers (St. 
Joseph’s Hospital). 
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Table S2. PRISMA checklist.  
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Table S3. Detailed quality assessment of the studies included in the meta-analysis 
according to the Cochrane Handbook and the Jadad score. In the own quality assessment 
of the randomization protocols, the level of randomization was assessed as good, medium 
and low.  
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Figure S1. Axial CT image of the patient admitted with severe TBI, obtained at time of 
arrival to level 1 trauma center. TBI comprised diffuse bilateral subarachnoid hemorrhage, 
bilateral frontal contusions, small right subdural hematoma, and effacement of basal 
cisterns secondary to cerebral edema. 
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Figure S2. Calculation method of the cooling index and examples for high (A and B), 
moderate (C), and low (D) calculated values. The shown examples were calculated from 
the cooling parameters reported by Smrcka et al. (2005) (A), Clifton et al. (1993) (B), 
Shiozaki et al. (2001) (C), and Marion et al. (1997) (D). In all panels, the striped area 
represents the cooling index; the calculated values are indicated. Dotted gray line 
illustrates normal (not cooled) deep body temperature considered as 36.5°C. ΔT, 
difference between normal body temperature and cooling target temperature; t, cooling 
duration; R, rate of rewarming. See main text for detailed explanation.  
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Figure S3. Forest plot of the odds ratios for mortality rate between cooled and not cooled 
groups of patients with severe TBI using random-effects model in 27 trials of all study 
types.  
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Figure S4. Forest plot of the odds ratios for mortality rate between cooled and not cooled 
groups of patients with severe TBI using random-effects model in all RCTs.  
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Figure S5. Forest plot of the odds ratios for mortality rate between cooled and not cooled 
groups of patients with severe TBI in RCT subgroups of good (group label 1), medium 
(group label 2), and low (group label 3) level of randomization protocols. The lines marked 
with * denote the mean values of the respective subgroups. 
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Figure S6. Funnel plot of 27 studies included in Figure S3.  
Here, and in Figures S7-S9, open circles represent results from studies included in the 
forest plot, while closed circles indicate studies that appeared to be missing according to 
the trim and fill method of Duval and Tweedie. Open and closed diamonds represent the 
average estimated effect size without (open diamond) and with trim and fill correction 
(closed diamond). Duval and Tweedie corrected value: 1.37 (95% CI, 1.00, 1.88).  
  
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ite
it 
U
tre
ch
t f
ro
m
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
4/
21
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Page 50 of 52 
 
 
 
50 
Jo
ur
na
l o
f N
eu
ro
tr
au
m
a 
Th
er
ap
eu
tic
 w
ho
le
-b
od
y 
hy
po
th
er
m
ia
 re
du
ce
s m
or
ta
lit
y 
in
 se
ve
re
 tr
au
m
at
ic 
br
ai
n 
in
ju
ry
 if
 th
e 
co
ol
in
g 
in
de
x i
s s
uf
fic
ie
nt
ly
 h
ig
h:
 m
et
a-
an
al
ys
es
 o
f t
he
 e
ffe
ct
 o
f s
in
gl
e 
co
ol
in
g 
pa
ra
m
et
er
s a
nd
 th
ei
r i
nt
eg
ra
te
d 
m
ea
su
re
 (D
OI
: 1
0.
10
89
/n
eu
.2
01
8.
56
49
) 
Th
is 
pa
pe
r h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 co
py
ed
iti
ng
 a
nd
 p
ro
of
 co
rr
ec
tio
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f. 
 
Figure S7. Funnel plot of 19 studies included in Figure S4. Duval and Tweedie trim and fill 
corrected value: 0.86 (95% CI, 0.65, 1.13).  
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Figure S8. Funnel plot of 14 studies included in Figures 2-5, 7, and S5. Duval and Tweedie 
trim and fill corrected value: 0.70 (95% CI, 0.53, 0.92); p = 0.509 with Egger’s test.  
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Figure S9. Funnel plot of 12 studies included in Figure 6. Duval and Tweedie trim and fill 
corrected value: 0.73 (95% CI, 0.52, 1.03); p = 0.474 with Egger’s test.  
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